Amgen acquires Micromet - MarketLine Financial Deals

Amgen acquires Micromet

Amgen acquires Micromet - MarketLine Financial Deals
Amgen acquires Micromet
Published Mar 07, 2012
4 pages — Published Mar 07, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Amgen, Inc., a biotechnology company, through its wholly-owned subsidiary Merger Sub, has acquired all outstanding shares of common stock of Micromet, Inc.

  
Source:
Document ID
MA96542_120130
Country
Ticker
AMGN=US
Ticker
MITI=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Amgen acquires Micromet" Mar 07, 2012. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Amgen-acquires-Micromet-2052-76729>
  
APA:
MarketLine Financial Deals. (2012). Amgen acquires Micromet Mar 07, 2012. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Amgen-acquires-Micromet-2052-76729>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.